The pharmaceutical supply chain: DCAT Week
The pharmaceutical supply chain will be the focus later this month at a series of educational sessions held Mar. 19–22 during
the Drug, Chemical, and Associated Technologies Association's (DCAT, Robbinsville, NJ,
http://www.dcat.org/) annual program in New York City.
DCAT is a 365-member company association that consists of firms that manufacture, distribute, or provide services to the pharmaceutical,
chemical, nutritional, and related industries. Its members include professionals engaged in sourcing, procurement, and supply-chain
management from large- and medium-sized innovator pharmaceutical companies, generic drug companies, and consumer healthcare
companies. On the supply side, DCAT's membership consists of manufacturers and distributors of active pharmaceutical ingredients,
intermediates, other pharmaceutical ingredients, formulation services, pharmaceutical packaging, and related services.
On Monday Mar. 19, DCAT will hold its Fifth Annual International Business Forum: Pharmaceutical Manufacturing: The Next Wave of Transformation, which will examine the latest changes in the pharmaceutical supply chain, including input from Charles M. Shafran, vice-president,
strategic planning from Pfizer Global Manufacturing, who will discuss divestiture of pharmaceutical manufacturing assets.
On Tuesday Mar. 20, DCAT will hold its Business Perspective Program, which will explain how the pharmaceutical industry is working with the Business for Social Responsibility (San Francisco, CA,
http://www.bsr.org/), a nonprofit business membership and advisory organization, to develop the Pharmaceutical Industry Principles for Responsible
Supply Chain Management.
Also on Mar. 20, DCAT will hold a session addressing the evolving regulatory environment for chemical registration in China
and its impact on the supply chain.
Other programs designed for DCAT member companies include sessions on over-the-counter drug packaging and human resource development
for the pharmaceutical chemical industry.
On Mar. 21, DCAT will present the IMS Health (Fairfield, CT,
http://www.imshealth.com/) annual pharmaceutical outlook. The DCAT Annual Dinner will be held Thursday, Mar. 22. This annual black-tie event this
year will feature Sir Richard Branson, founder and chairman of the Virgin Group as the guest speaker.
Full details about the programs may be found at
1. P. Van Arnum, "The Changing Fortunes of APIs," Pharm. Technol. 31 (1), 52–58 (2006).